Serge Saxonov

During its first-quarter earnings call on Thursday, 10x Genomics Inc. (NASDAQ:TXG) withdrew its full-year guidance, opting instead to provide quarterly forecasts. What Happened: The company cited policy uncertainty stemming from recent U.S. government budget cuts for academic research as the...

Serge Saxonov, Chief Executive Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Serge Saxonov exercised options to purchase 8,...